Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Alma Habib, Isaiah Boateng, Diana Abbott, Deedra Nicolet, Krzysztof Mrózek, James Fisher, Allyson Waller, Jill Buss, Andrea Laganson, Ethan Hamp, Yazan Abu-Shihab, Bayard Powell, Geoffrey Uy, Wendy Stock, Richard Stone, Jonathan Kolitz, Eunice Wang, Andrew Carroll, Jeffrey Tyner, Andrew Hantel, Craig Jordan, Electra Paskett, John Byrd, Elaine Mardis, Jesse Plascak, Ann-Kathrin Eisfeld
Institutions: The Ohio State University Wexner Medical Center, University of Kansas Medical Center, Colorado School of Public Health, University of Colorado Anschutz, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Atrium Health Wake Forest Baptist, Washington University in St. Louis, University of Chicago, Dana-Farber Cancer Institute, Northwell Health, Roswell Park Comprehensive Cancer Center, University of Alabama at Birmingham, Oregon Health & Science University, University of Colorado Denver, University of Cincinnati, Nationwide Children's Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417018592
Cites:
Cited by:
Related to: